Brief: SkinBioTherapeutics Announces CFO Emily Bertram To Leave Co On June 30
BRIEF-SkinBioTherapeutics Announces CFO Emily Bertram To Leave Co On June 30 June 25 (Reuters) - SkinBioTherapeutics PLC SBTX.L:
SKINBIOTHERAPEUTICS - DIRECTORATE CHANGE
SKINBIOTHERAPEUTICS - EMILY BERTRAM, CFO, TO LEAVE SKINBIOTHERAPEUTICS ON 30 JUNE 2026
SKINBIOTHERAPEUTICS - ENGAGES INTERIM CFO AND INITIATES SEARCH FOR PERMANENT CFO
Source text: ID:nRSY8023Ja
Further company coverage: SBTX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company